FDA inspection
Sichuan D-Innovation Pharmaceutical Co., Ltd.: FDA inspection ending Mar 14, 2025
FDA inspection 1266936 · Voluntary Action Indicated (VAI) · Meishan
Key facts
| Inspection ID | 1266936 |
|---|---|
| Firm | Sichuan D-Innovation Pharmaceutical Co., Ltd. |
| FEI number | 3009432595 |
| Address | New, No. 13 Yulan Road, Western Medical Valley; Dongpo District |
| City | Meishan |
| Fiscal year | 2025 |
| Inspection end date | Mar 14, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data